AMN HEALTHCARE SERVICES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMN HEALTHCARE SERVICES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $509.08M | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | $494.41M | Feb 16, 2018 |
| FY2017 | Jun 30, 2017 | $489.80M | Feb 16, 2018 |
| FY2017 | Mar 31, 2017 | $495.17M | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $487.86M | Feb 16, 2018 |
| FY2017 | Sep 30, 2016 | $472.64M | Feb 16, 2018 |
| FY2017 | Jun 30, 2016 | $473.73M | Feb 16, 2018 |
| FY2017 | Mar 31, 2016 | $468.00M | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | $402.55M | Feb 17, 2017 |
| FY2016 | Sep 30, 2015 | $382.86M | Feb 17, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.73B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.98B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $3.79B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $5.24B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $3.98B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $631.27M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $551.63M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $608.35M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $602.46M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $586.89M | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $774.06M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $919.38M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.25B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.72B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.31B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $207.54M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $184.63M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $197.54M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $202.07M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $197.13M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($95.70M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($146.98M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $210.68M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $444.05M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $327.39M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $9.31M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $26.07M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $22.33M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $12.97M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $27.48M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($55.47M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($102.67M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $338.43M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $647.10M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $478.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $149.27M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $176.92M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $202.83M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $212.44M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $191.63M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $593.02M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $632.49M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $748.44M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $936.58M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $730.45M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $549.75M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $508.03M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $452.32M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $399.70M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $398.47M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $269.46M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $320.42M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $372.17M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $653.73M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $305.36M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $256.83M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $224.86M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $226.99M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $160.52M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $133.91M | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.63M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $80.89M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $103.69M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $75.83M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $53.57M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $37.70M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $35.22M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $35.21M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $26.53M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $21.96M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.42B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.92B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.89B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.13B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.35B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.93B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.49B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.25B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.19B | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.45B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.71B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.09B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.84B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.97B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.53B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.19B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $853.73M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $691.43M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $737.50M | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $642.11M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $706.62M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $831.26M | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $1.04B | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $1.16B | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $819.68M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $736.74M | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | $638.99M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $562.53M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $449.38M | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $755.81M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $897.46M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.11B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $935.36M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $892.34M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $864.49M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $595.55M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $438.51M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $340.60M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $341.75M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.30B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.45B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.24B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $796.95M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $469.56M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $400.05M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $286.06M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $142.23M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $9.67M | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.97M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $10.65M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $32.94M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $64.52M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $180.93M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $29.21M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $82.99M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $13.86M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $15.15M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $10.62M | Feb 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $767.05M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.06B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.30B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $843.51M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $842.32M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $857.96M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $617.16M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $440.61M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $319.84M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $359.19M | Feb 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 38.44M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 38.08M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 37.81M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 41.88M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 47.26M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 47.05M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 46.72M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 46.64M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 47.48M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 47.61M | Feb 16, 2018 |